About Aleksander Popel, PhD
Form D filings for AsclepiX Therapeutics from 2017 to 2024 list Aleksander Popel, PhD as executive officer.
Aleksander Popel, PhD first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Aleksander Popel, PhD in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Aleksander Popel, PhD works with at each company, as listed on that company's latest Form D.
AsclepiX Therapeutics, Inc. · Form D, Apr 26, 2024
RD
Robert Dempsey
Chief Executive Officer
Steven Altschuler
Director
BA
Ben Askew
Director
JB
Josh Barer
Director
CG
Chris Garabedian
Director
SS
Sapna Srivastava
Director
AS
Amir Shojaei
Executive officer
NP
Niranjan Pandey
Executive officer
JT
Jill Tierney
Executive officer
JG
Jordan Green
Director